Bruce V Taylor
Bruce V Taylor
menzies Research Institute Tasmania University of Tasmania
Verified email at
Cited by
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ...
Nature 476 (7359), 214, 2011
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
JZ Liu
Nature genetics 47 (9), 979-986, 2015
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
X Montalban
New England Journal of Medicine, 2017
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ...
Nature genetics 45 (11), 1353, 2013
Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity
P Browne, D Chandraratna, C Angood, H Tremlett, C Baker, BV Taylor, ...
Neurology 83 (11), 1022-1024, 2014
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ...
Nature genetics 41 (7), 776, 2009
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
S Simpson, L Blizzard, P Otahal, I Van der Mei, B Taylor
Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1132-1141, 2011
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ...
Bmj 327 (7410), 316, 2003
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
S Simpson Jr, B Taylor, L Blizzard, AL Ponsonby, F Pittas, H Tremlett, ...
Annals of neurology 68 (2), 193-203, 2010
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Australia and New Zealand Multiple Sclerosis Genetics Consortium
Nature genetics 41 (7), 824, 2009
The fine-scale genetic structure of the British population.
s Leslie
Nature 519 (7543), 2015
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ...
Journal of neurology 254 (5), 581-590, 2007
Sun exposure and vitamin D are independent risk factors for CNS demyelination
RM Lucas, AL Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, ...
Neurology 76 (6), 540-548, 2011
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
NA Patsopoulos, ...
Annals of neurology 70 (6), 897-912, 2011
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
F Lublin, D Miller
Lancet 387 (10023), 1075-84, 2016
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
EK Mathey, SB Park, RAC Hughes, JD Pollard, PJ Armati, MH Barnett, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (9), 973-985, 2015
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
B Wood, IAF Van Der Mei, AL Ponsonby, F Pittas, S Quinn, T Dwyer, ...
Multiple Sclerosis Journal 19 (2), 217-224, 2013
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood
MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ...
PloS one 5 (8), e12132, 2010
Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects
NA Patsopoulos, LF Barcellos, RQ Hintzen, C Schaefer, CM Van Duijn, ...
PLoS Genet 9 (11), e1003926, 2013
Diabetic neuropathies: classification, clinical features, and pathophysiological basis
M Sinnreich, BV Taylor, PJB Dyck
The neurologist 11 (2), 63-79, 2005
The system can't perform the operation now. Try again later.
Articles 1–20